eNOS knockout mice with advanced diabetic nephropathy have less benefit from renin-angiotensin blockade than from aldosterone receptor antagonists (Q33597090)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	eNOS knockout mice with advanced diabetic nephropathy have less benefit from renin-angiotensin blockade than from aldosterone receptor antagonists	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

28 July 2017

eNOS knockout mice with advanced diabetic nephropathy have less benefit from renin-angiotensin blockade than from aldosterone receptor antagonists (English)

1 reference

Europe PubMed Central

28 July 2017

0 references

diabetic nephropathy

1 reference

based on heuristic

inferred from title

Takahiko Nakagawa

5

object named as

Takahiko Nakagawa

1 reference

Europe PubMed Central

28 July 2017

author name string

Tomoki Kosugi

1

1 reference

Europe PubMed Central

28 July 2017

Marcelo Heinig

2

1 reference

Europe PubMed Central

28 July 2017

Takahiro Nakayama

3

1 reference

Europe PubMed Central

28 July 2017

Seiichi Matsuo

4

1 reference

Europe PubMed Central

28 July 2017

language of work or name

0 references

publication date

30 December 2009

1 reference

Europe PubMed Central

28 July 2017

The American Journal of Pathology

1 reference

Europe PubMed Central

28 July 2017

176

1 reference

Europe PubMed Central

28 July 2017

619-629

1 reference

Europe PubMed Central

28 July 2017

2

1 reference

Europe PubMed Central

28 July 2017

Renal and retinal effects of enalapril and losartan in type 1 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808070

21 June 2018

Lowering blood pressure blocks mesangiolysis and mesangial nodules, but not tubulointerstitial injury, in diabetic eNOS knockout mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808070

21 June 2018

The incidence and implications of aldosterone breakthrough

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808070

21 June 2018

Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808070

21 June 2018

Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808070

21 June 2018

Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808070

21 June 2018

Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for nonproteolytic activation of prorenin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808070

21 June 2018

Brachial artery reactivity in asymptomatic patients with type 2 diabetes mellitus and microalbuminuria (from the Detection of Ischemia in Asymptomatic Diabetics-brachial artery reactivity study).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808070

21 June 2018

Aldosterone in the development and progression of renal injury

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808070

21 June 2018

Differential regulation of VEGF by TGF-beta and hypoxia in rat proximal tubular cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808070

21 June 2018

Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808070

21 June 2018

ACE inhibitor improves insulin resistance in diabetic mouse via bradykinin and NO.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808070

21 June 2018

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808070

21 June 2018

Aliskiren combined with losartan in type 2 diabetes and nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808070

30 October 2018

Renal angiotensin II concentration and interstitial infiltration of immune cells are correlated with blood pressure levels in salt-sensitive hypertension.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808070

30 October 2018

Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808070

30 October 2018

Vascular defect beyond the endothelium in type II diabetic patients with overt nephropathy and moderate renal insufficiency.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808070

30 October 2018

Impaired vascular reactivity in African-American patients with type 2 diabetes mellitus and microalbuminuria or proteinuria despite angiotensin-converting enzyme inhibitor therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808070

30 October 2018

Regression of microalbuminuria in type 1 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808070

30 October 2018

Antihypertensive Drug Utilization in Hypertensive Veterans With Complex Medication Profiles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808070

30 October 2018

Glomerular size-selective dysfunction in NIDDM is not ameliorated by ACE inhibition or by calcium channel blockade

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808070

30 October 2018

ACE-inhibitor use and the long-term risk of renal failure in diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808070

30 October 2018

Baroreflex sensitivity in rabbits during the development of experimental renal hypertension and medial sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20042665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aliskiren, a novel renin inhibitor, is renoprotective in a model of advanced diabetic nephropathy in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/20042665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of ACE inhibitors as renoprotective agents in Medicaid patients with diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20042665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sympathetic baroreceptor responses after chronic NG-nitro-L-arginine methyl ester treatment in conscious rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/20042665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Midkine is involved in tubulointerstitial inflammation associated with diabetic nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20042665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mouse models of diabetic nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20042665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-deficient mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/20042665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is associated with low circulating adiponectin

1 reference

https://pubmed.ncbi.nlm.nih.gov/20042665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/20042665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2353/AJPATH.2010.090578

1 reference

Europe PubMed Central

28 July 2017

1 reference

Europe PubMed Central

28 July 2017

1 reference

Europe PubMed Central

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33597090&oldid=1950495371"